مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

287
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

129
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

ASSOCIATION OF SERUM SOLUBLE LEPTIN RECEPTOR AND LEPTIN LEVELS WITH BREAST CANCER

Pages

  433-438

Abstract

 Background: LEPTIN plays a key role in the regulation of energy expenditure and is known to circulate in both free and bound forms. Soluble LEPTIN receptor (sOB-R) is a unique circulating form of LEPTIN receptor that can bind to LEPTIN. LEPTIN and LEPTIN receptor have been implicated in processes leading to BREAST CANCER initiation and progression. Our study was aimed to investigate the relationship between serum levels of sOB-R and LEPTIN with BREAST CANCER.Materials and Methods: Serum LEPTIN and sOB-R levels were measured by enzyme-linked immunosorbent assay in 100 women with BREAST CANCER cases compared with 100 age and body mass index (BMI)-matched controls without cancer. Lipid profiles were measured by enzymatic method.Results: The median serum levels of sOB-R in controls were significantly higher than that in BREAST CANCER cases (odds ratio [OR], 1.98; 95% confidence interval [CI] =0.77-188.2) versus (OR, 0.140; 95% CI=0.09-98.1). Conversely, the median serum level of LEPTIN in BREAST CANCER cases was significantly higher than that in controls (OR, 67.90; 95% CI=2.77-129.9) vs. (OR, 28.30; 95% CI=0.60-113.1). BREAST CANCER was significantly associated with higher serum level of LEPTIN (OR=1.027, 95% CI=1.017-1.038). Conversely, BREAST CANCER was correlated with lower serum level of sOB-R (OR=0.983, 95% CI=0.969-0.997). Moreover, LEPTIN INDEX/fa?page=1&sort=1&ftyp=all&fgrp=all&fyrs=all" target="_blank"> FREE LEPTIN INDEX (FLI) (leptin/sOB-R ratio) was associated with BREAST CANCER (OR=1.028, 95% CI=1.015-1.042). The serum sOB-R level was negatively associated with LEPTIN, BMI, and high density lipoprotein (r=-0.238, -0.186, and -0.168, respectively).Conclusion: Our results suggested that FLI and serum LEPTIN level rather than serum level of sOB-R was associated with the BREAST CANCER.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    MOHAMMADZADEH, GHORBAN, GHAFFARI, MOHAMMAD ALI, BAFANDEH, AHMAD, & HOSSEINI, SEYED MOHAMMAD. (2014). ASSOCIATION OF SERUM SOLUBLE LEPTIN RECEPTOR AND LEPTIN LEVELS WITH BREAST CANCER. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 19(5), 433-438. SID. https://sid.ir/paper/630391/en

    Vancouver: Copy

    MOHAMMADZADEH GHORBAN, GHAFFARI MOHAMMAD ALI, BAFANDEH AHMAD, HOSSEINI SEYED MOHAMMAD. ASSOCIATION OF SERUM SOLUBLE LEPTIN RECEPTOR AND LEPTIN LEVELS WITH BREAST CANCER. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2014;19(5):433-438. Available from: https://sid.ir/paper/630391/en

    IEEE: Copy

    GHORBAN MOHAMMADZADEH, MOHAMMAD ALI GHAFFARI, AHMAD BAFANDEH, and SEYED MOHAMMAD HOSSEINI, “ASSOCIATION OF SERUM SOLUBLE LEPTIN RECEPTOR AND LEPTIN LEVELS WITH BREAST CANCER,” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 19, no. 5, pp. 433–438, 2014, [Online]. Available: https://sid.ir/paper/630391/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button